Click on a filter below to refine your search. Remove a filter to broaden your search.
The prevalence was highest among non-Hispanic Black people (15.8%) and individuals aged 65 years and older (23.86%).
A considerable decrease was estimated in US adults receiving or recommended for preventive treatment with statins and antihypertensives.
Higher levels of gratitude were tied to a 9% reduction in all-cause mortality and a 15% reduction in cardiovascular death.
Current smoking, diabetes mellitus and higher fasting glucose level all were linked to lower prevalence of migraine in women.
Polypharmacy increased, peaking at 43.0% in 2017 to March 2020; hyperpolypharmacy increased during 1999-2000 to 2007-2008.
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
Estimated mean change from baseline in HbA1c was −2.1% with tirzepatide, which met noninferiority criteria and achieved superiority.
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
Significant improvement in mean visual acuity was seen within 24 hours of treatment; clinically significant improvement occurred in 66%.
MPV ≥10.2 fL was independently associated with all-cause mortality and cardiovascular mortality.